released the findings of a study
which examines how device usability impacts patient acceptance, dosage compliance and ultimately health outcomes. Looking at the role lifestyle factors and device features play in patient compliance for drug and device combination products, the research supports the idea that pharmaceutical companies could improve the market share of their drugs if the emphasis was shifted to the broader patient user experience.
Participants in the survey included healthcare providers, which play critical roles in determining a drug’s market success, and over 240 diabetes patients who used combination products daily, such as injection pens, auto-injectors or insulin pumps.
Responses indicated that patient compliance directly influences patient health and drug efficacy, suggesting that delivery device design should be focussed on supporting compliance on multiple levels.